Nicorandil a magic bullet or a double edged sword in critically ill COVID-19 patients?
- PMID: 33684970
- PMCID: PMC8250650
- DOI: 10.1111/1440-1681.13487
Nicorandil a magic bullet or a double edged sword in critically ill COVID-19 patients?
Keywords: COVID-19 pandemic; nicorandil; pleotropic action; potassium ATP channels; potassium channel syndrome.
Conflict of interest statement
Nothing to declare.
Comment on
-
Hypothesis: The potential therapeutic role of nicorandil in COVID-19.Clin Exp Pharmacol Physiol. 2020 Nov;47(11):1791-1797. doi: 10.1111/1440-1681.13395. Epub 2020 Sep 9. Clin Exp Pharmacol Physiol. 2020. PMID: 32881062 Free PMC article. Review.
References
-
- Montgomery H, Sumeray M, Carr C, Singer M. Sinus arrest and severe peripheral vasodilation following cardiopulmonary bypass in a patient taking nicorandil. Cardiovasc Drugs Ther. 1997;11(1):81. - PubMed
-
- Markham A, Plosker GL, Nicorandil GKL. An updated review of its use in Ischaemic heart disease with emphasis on its cardio protective effects. Drugs. 2000;60:955‐974. - PubMed
-
- Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev. 2000;52:557‐594. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
